Pegasys Hoffmann-La Roche - Treatment for Chronic Hepatitis C
Pegasys is a long acting interferon indicated for the treatment of adults with chronic hepatitis C who have compensated liver disease and who have not been previously treated with interferon alfa.Posted: October 2002
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
